Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Catalent, Novo Nordisk and FTC
Consumer groups ask FTC to block Novo Holdings-Catalent deal
U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo Holdings, the controlling shareholder of Novo Nordisk , from acquiring contract drug manufacturer Catalent ,
Consumer, labor groups urge FTC to block Catalent sale to Novo Nordisk - report
Five U.S. consumer groups and two big labor unions are pushing for the Federal Trade Commission to block Novo Nordisk Foundation's planned $16.5 billion acquisition of Catalent (NYSE:CTLT), arguing that a deal would hurt competition in weigh-loss drugs.
Consumer and Labor Unions Oppose Novo's Catalent Acquisition
U.S. consumer groups and labor unions have called on the Federal Trade Commission to block Novo Holdings from acquiring Catalent, a contract drug manufacturer. Concerns focus on competition in weight-loss drugs and gene therapies.
US Senator Warren calls for scrutiny of Novo Holdings' Catalent deal
U.S. Senator Elizabeth Warren has asked antitrust regulators to scrutinize a $16.5 billion deal in which Novo Nordisk's controlling shareholder would acquire contract drug manufacturer Catalent, saying it may give the pharmaceutical company an unlawful advantage in obesity drugs.
Pressure Mounts on Novo’s $16.5B Catalent Buy Amid FTC Review
Senator Elizabeth Warren told the Federal Trade Commission that the acquisition of contract manufacturer Catalent could increase Novo’s dominance over the hot GLP-1 market, reducing competition and increasing prices.
FTC Urged to Block Novo Holdings' Catalent Acquisition Amid Competition Concerns
U.S. consumer groups and labor unions are urging the FTC to block Novo Holdings' acquisition of Catalent. They argue it could stifle competition for weight loss drugs and gene therapies, affecting companies like Amgen and Pfizer.
FTC Faces Pressure to Block Novo Nordisk-Catalent Merger Over Antitrust Fears
Concerns are rising as Novo Nordisk's $16.5 billion bid to acquire Catalent faces scrutiny from the FTC. Critics argue the merger could harm competition in the GLP-1 market, potentially driving up prices for obesity and diabetes treatments.
Novo Holdings' $16.5B Catalent buyout in crosshairs as consumer groups ask FTC to block the deal
Novo Holdings is encountering more resistance as it aims to close its $16.5 billion acquisition of pharma manufacturing giant Catalent by the end of the year. | A dozen consumer groups and trade unions penned a letter to Lina Khan,
Consumer and labor groups urge FTC to block Catalent sale to Novo Holdings
The coalition said in a letter sent to the FTC Thursday that the deal could reduce access to GLP-1s, and harm competition in development of cell and gene therapies.
22h
on MSN
After US Senator, Unions Urge Federal Trade Commission To Block Novo's $16.5B Acquisition Of Catalent
Public interest groups are urging the FTC to block Novo Holdings' $16.5 billion acquisition of Catalent, citing concerns over ...
STAT
9d
Warren urges FTC to probe deal that would give Novo Nordisk control of some Catalent plants
U.S. Sen. Elizabeth Warren has asked the Federal Trade Commission “closely scrutinize” a $16.5 billion deal in which
Novo
...
1d
Consumer, labor groups urge FTC to block Catalent sale to Novo Holdings - report
Financial groups and labor unions urge FTC to block Nordisk Foundation's acquisition of Catalent, citing concerns about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Reaches tentative union deal
Judge unseals new evidence
Preliminary cause of death
Frozen waffles recalled
La Nina could arrive soon
Republicans appeal ruling
Ex-MN congressman dies
NC breaks turnout record
Nationwide blackout in Cuba
Challenges military listing
PG&E shuts off power
NK sending troops to RU?
Bladder cancer drug pulled
Emergency abortion ruling
$4M LAPD fentanyl seizure
FAA opens new safety review
Opioid suits settlement deal
Probes near miss in Austin
Antitrust ruling delayed
‘Full Self-Driving’ probe
US deficit reaches $1.8T
At decade-high level
To furlough 700 workers
Nevada US Senate debate
School shooting report
Eases voting rules
Fire prompts evacuations
Three Americans detained
Feedback